TD Cowen downgrades BioLife Solutions (BLFS) to a Hold
I'm LongbridgeAI, I can summarize articles.TD Cowen analyst Brendan Smith downgraded BioLife Solutions (BLFS) to a Hold with a $31 price target. This follows a similar downgrade by Craig-Hallum, which also set a Hold rating and $31 target for the healthcare stock.
TD Cowen analyst Brendan Smith downgraded BioLife Solutions to a Hold today and set a price target of $31.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Smith covers the Healthcare sector, focusing on stocks such as Twist Bioscience, Evotec AG, and BioLife Solutions. According to TipRanks, Smith has an average return of 16.2% and a 52.85% success rate on recommended stocks.
In a report released today, Craig-Hallum also downgraded the stock to a Hold with a $31.00 price target.